CHARACTERISTICS ASSOCIATED WITH THE CHOICE OF FIRST INJECTABLE THERAPY AMONG US PATIENTS WITH TYPE 2 DIABETES

The clinically relevant differences observed between the 2 patient populations suggest that GLP-1-RAs and basal insulin are prescribed to different types of patients with T2DM. Examining patients' demographic and clinical characteristics may be important in assisting physicians in the choice of patient-centered injectable treatment regimens.